title: Severe sporotrichoid fishtank granuloma following infliximab therapy for Crohn's disease.
authors.forename: B
authors.initials: B
authors.lastname: Ben Said
authors.forename: J
authors.initials: J
authors.lastname: Kanitakis
authors.forename: I
authors.initials: I
authors.lastname: Graber
authors.forename: F
authors.initials: F
authors.lastname: Berard
authors.forename: J F
authors.initials: JF
authors.lastname: Nicolas
authors.forename: J C
authors.initials: JC
authors.lastname: Saurin
authors.forename: F
authors.initials: F
authors.lastname: Augey
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D005399:Fishes / Q000382:microbiology*; D006099:Granuloma / Q000150:complications* / Q000276:immunology; D006686:Hobbies; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D013174:Sporotrichosis / Q000150:complications* / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab